Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients
Clinical trial NCT03644485 · COMPLETED
Trial details
- NCT number
- NCT03644485
- Sponsor
- Astellas Pharma China, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-21
- Primary completion
- 2022-07-15
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.